Biology:BCL2L2

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Bcl-2-like protein 2 is a 193-amino acid protein that in humans is encoded by the BCL2L2 gene on chromosome 14 (band q11.2-q12).[1][2][3] It was originally discovered by Leonie Gibson, Suzanne Cory and colleagues at the Walter and Eliza Hall Institute of Medical Research, who called it Bcl-w.[4]

Function

This gene encodes a pro-survival (anti-apoptotic) member of the bcl-2 protein family, and is most similar to Bcl-xL.[3] The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators. Expression of this gene in cells has been shown to contribute to reduced cell apoptosis under cytotoxic conditions. Studies of the related gene in mice indicated a role in the survival of NGF- and BDNF-dependent neurons. Mutation and knockout studies of the mouse gene demonstrated an essential role in adult spermatogenesis.[2][5][3]

Clinical significance

High levels of Bcl-w are seen in many cancers, including glioblastoma, colorectal cancer, non-small-cell lung carcinoma, and breast cancer.[3] Breast cancer patients with metastasis have higher Bcl-w than breast cancer patients only having primary tumor.[3] Elevated levels of Bcl-w has been shown to protect neurons from cell death induced by amyloid beta.[3] Parkinson's disease patients with a mutant PARK2 gene have elevated Bcl-w.[3] Bcl-w has been shown to contribute to cellular senescence.[3]

Quercetin has been shown to inhibit the PI3K/AKT pathway leading to downregulation of Bcl-w.[6][3]

Interactions

BCL2L2 has been shown to interact with:

References

  1. "bcl-w, a novel member of the bcl-2 family, promotes cell survival". Oncogene 13 (4): 665–75. October 1996. PMID 8761287. 
  2. 2.0 2.1 "Entrez Gene: BCL2L2 BCL2-like 2". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=599. 
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 "BCL-w: apoptotic and non-apoptotic role in health and disease". Cell Death & Disease 11 (4): 2260. 2020. doi:10.1038/s41419-020-2417-0. PMID 32317622. 
  4. "bcl-w, a novel member of the bcl-2 family, promotes cell survival.". Oncogene 13 (4): 665–75. 1996. PMID 8761287. 
  5. Kelly, Gemma L.; Strasser, Andreas (2020). "Toward Targeting Antiapoptotic MCL-1 for Cancer Therapy". Annual Review of Cancer Biology 4: 299–313. doi:10.1146/annurev-cancerbio-030419-033510. 
  6. "Targeting senescent cells in translational medicine". EMBO Molecular Medicine 11 (12): e10234. 2019. doi:10.15252/emmm.201810234. PMID 31746100. 
  7. "BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members". Mol. Endocrinol. 12 (9): 1432–40. September 1998. doi:10.1210/mend.12.9.0166. PMID 9731710. 
  8. "Bim: a novel member of the Bcl-2 family that promotes apoptosis". EMBO J. 17 (2): 384–95. January 1998. doi:10.1093/emboj/17.2.384. PMID 9430630. 
  9. 9.0 9.1 "The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad". Eur. J. Immunol. 32 (7): 1847–55. July 2002. doi:10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7. PMID 12115603. 
  10. "Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function". Mol. Cell 17 (3): 393–403. February 2005. doi:10.1016/j.molcel.2004.12.030. PMID 15694340. 
  11. "Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis". Apoptosis 6 (5): 319–30. October 2001. doi:10.1023/A:1011319901057. PMID 11483855. 
  12. "Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members". Cell Death Differ. 6 (6): 525–32. June 1999. doi:10.1038/sj.cdd.4400519. PMID 10381646. 

Further reading

External links